Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yan-Lan Chai"'
Autor:
Bao-Zhong Zhang, Yang Li, Li-Ming Xu, Yan-Lan Chai, Chao Qu, Yuan-Jie Cao, Jing Wang, Hai-Ling Hou, Jiaqi Zhang
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Objective The purpose of this study is to verify the correlation between medium and low radiation doses of the pelvic-bone marrow and the incidence of lymphocytic toxicity during concurrent chemoradiotherapy for cervical cancer. Materials an
Externí odkaz:
https://doaj.org/article/fa36cd517ab140afb498d24b9128d612
Publikováno v:
Molecular and Clinical Oncology. 3:363-366
The recurrence and metastasis of cervical cancer contribute to a poor prognosis. The aim of this study was to investigate the risk factors for cervical cancer progression. A total of 284 patients with recurrent cervical cancer were retrospectively re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3664fe7bf1f0fe5f4fce1d43c22cdc6
https://doi.org/10.3892/mco.2014.465
https://doi.org/10.3892/mco.2014.465
Publikováno v:
Oncology Letters. 2014, Vol. 8 Issue 1, p82-84. 3p.
Publikováno v:
Oncology Letters
Solid tumors following myelodysplastic syndrome (MDS) are rare and have no uniform treatment guidelines. The current study presents a rare case of a 47-year-old female diagnosed with cervical cancer (International Federation of Gynecology and Obstetr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58154232587c70f155c56af3b6dc7b54
https://pubmed.ncbi.nlm.nih.gov/24959223
https://pubmed.ncbi.nlm.nih.gov/24959223
Publikováno v:
Therapeutics and Clinical Risk Management
Yunyi Yang, Zi Liu, Juan Wang, Yanlan Chai, Jin Su, Fan Shi, Jiquan Wang, Shao Min Che Department of Radiation Oncology, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an, Shanxi, People’s Republic of China Abst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c4d8f89c398dfacee6405f041f4cbe
https://doi.org/10.2147/tcrm.s101346
https://doi.org/10.2147/tcrm.s101346
Publikováno v:
Molecular & Clinical Oncology; 2015, Vol. 3 Issue 2, p363-366, 4p